High-Intensity vs Low-Intensity PEMF: What the Difference Means
PEMF systems span several orders of magnitude in output. Both approaches have published research behind them. Intensity describes a design choice, not a quality tier, and the industry does not report it consistently enough to compare reliably.
Manufacturer statements sourced from their own published material, verified August 2026.
What are the two approaches?
Pulse PEMF, a high-intensity manufacturer, frames the market in two categories. Resonant systems deliver a repeating low-intensity waveform, such as a sine, square or sawtooth signal. Impulse systems deliver a sudden high-intensity discharge. Their published intensity bands define low intensity as under 1,000 gauss and high intensity as 1,000 to 50,000 gauss.
Both designs are established. Resonant systems are common in home and full-body mat products, including the BioReg line. Impulse systems are common in clinic equipment built around a spark-gap or solid-state high-power discharge.
Source: Pulse PEMF, Low Intensity vs High Intensity PEMFWhy is gauss a difficult measure?
The clearest published explanation comes from a high-intensity manufacturer. In Pulse PEMF’s Gauss Explained article, their Specialty High Voltage Engineer compares a device outputting 40 gauss with one outputting 40,000 gauss and states both “would feel exactly the same to the user,” concluding that “this measurement is meaningless in terms of stimulation.” The pulse of the magnetic field, not its static strength, is what the body responds to. The same article notes that “an MRI machine can output 70,000 gauss” without stimulating anything, because “there is no change (or pulse) in the magnetic field.”
The article adds three practical measurement problems. Reported gauss varies moderately from machine to machine and greatly from accessory to accessory on the same machine. Output fluctuates over time. And one inch of separation between the applicator and the body halves field contact, so the figure on a datasheet is not the figure at the tissue.
Their summary position: “more gauss is not always better.” We present this as what it is, a manufacturer’s technical explanation of its own design philosophy, and on the measurement difficulty the physics is not controversial.
Source: Pulse PEMF, Gauss ExplainedWhat do manufacturers actually publish?
Pulse PEMF publishes no gauss figure for any machine, and states this is deliberate: “we reserve these estimates as proprietary information.” What they publish instead is relative control ranges, such as a 0 to 100 percent field strength dial.
BEMER publishes microtesla figures per applicator in its Instructions for Use, which is the most granular disclosure in the category. BioReg publishes a single figure, 100+ µT across the line. That is less granular than BEMER’s per-applicator disclosure, and we state that gap plainly.
The reporting problem is recognized in the literature. A 2022 systematic review in Wiener klinische Wochenschrift found that the studies it examined stated intensity in gauss, microtesla, millitesla, and volts per meter, and called for “an international consensus on the uniform reporting of the magnetic flux density” so that study protocols can be compared at all. Until that exists, cross-manufacturer intensity comparison rests on numbers that are not measured or reported the same way.
Source: Pulse PEMF, Gauss ExplainedSource: BEMER Therapy System Evo, Instructions for Use
Source: Markovic, Wagner, Crevenna. Wiener klinische Wochenschrift, 2022 (open access)
Does higher output produce better results?
The honest answer is that published research spans a wide intensity range and does not establish that higher output produces better outcomes. The Wiener klinische Wochenschrift review found studied field intensities running from 3.4 microtesla to 105 millitesla, with positive findings reported across that range.
The same rule we apply to competitors applies to us: a positive study at one intensity is not evidence for a device operating at another intensity. That is why the BioReg research library grades each study on its own parameters rather than transferring results between devices. See how we grade evidence.
Source: Markovic, Wagner, Crevenna. Wiener klinische Wochenschrift, 2022 (open access)What should you evaluate instead?
If intensity figures cannot be compared reliably, the useful questions are the ones manufacturers do answer consistently:
- Protocol range: how many distinct published programs the device offers, and across what frequency range.
- Practitioner editability: whether frequency, duration and intensity can be adjusted per patient, or fixed behind presets.
- Measurement capability: whether the device reads the patient during the session. The BioReg Nesta line is open-loop and performs no physiological measurement. CellCom, the closed-loop tier, does.
- Session capacity: how many patients or stations one controller supports.
- Training and service: what onboarding, continuing education, warranty and support are included.
These criteria are developed in clinical-grade vs consumer PEMF and applied to every BioReg device in the specification matrix.